NCT06633471View on ClinicalTrials.gov

Clinical Study Aimed At Evaluating the Safety and Efficacy of Tear Substitute Formulations in the Treatment of Dry Eye Disease.

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

175

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

April 30, 2025

Conditions

Dry Eye Disease (DED)

Interventions

DRUG

Two test formulations for the treatment of DED are being compared against the approved OTC formulation (Systane Ultra) and saline (placebo).

Rain and Mist are the test formulations. Systane Ultra is an approved OTC formulation. Saline is the placebo.

Trial Locations (1)

Unknown

Warrens Eye Care Centre, Bridgetown

All Listed Sponsors

lead

PS Therapy Inc.

OTHER

NCT06633471 - Clinical Study Aimed At Evaluating the Safety and Efficacy of Tear Substitute Formulations in the Treatment of Dry Eye Disease. | Biotech Hunter | Biotech Hunter